Centogene N.V.

CENTOGENE N.V. is a commercial precision-medicine and genetic diagnostics company headquartered in Rostock, Germany. Founded in 2006, it describes itself as having been "born to help diagnostic patients with rare disease" and has since evolved to serve patients across all clinical specialties through "guided solutions for physicians, their patients and pharma partners." Its stated mission is "Guiding Precision Medicine." The company operates a global footprint with offices and locations in Rostock, Berlin, Boston, Valencia, Belgrade, São Paulo, Delhi and Dubai, and it has expanded into Taiwan through CENTOGENE APAC. CENTOGENE's core business is genetic and genomic diagnostics. It offers comprehensive and custom next-generation sequencing (NGS) panels, whole-genome sequencing (WGS) through its CentoGenome product, exome-based reproductive carrier screening through CentoScreen Exome, and a pediatric-focused panel portfolio called CentoPediatric. Its CentoGenome Ultra-Fast service promises whole-genome sequencing results in just five business days. The company also provides CentoDx, an end-to-end genomic knowledge-management platform designed to streamline variant interpretation for experts. Beyond diagnostics, CENTOGENE operates a pharma business that partners with pharmaceutical companies to accelerate drug discovery and development, leveraging multiomic insights and real-world data to bring targeted therapies to patients faster. This is supported by the CENTOGENE Biodatabank, which contains data on more than one million individuals, and by a body of more than 350 peer-reviewed scientific publications. The company also runs a reproductive health offering that enables rapid and reliable identification of disease-causing mutations, even at early stages of pregnancy. CENTOGENE positions itself at the intersection of diagnostics, data and drug development, emphasizing multiomics and rare-disease expertise. It has pursued strategic partnerships and ownership moves, including taking ownership in Pearl Medical Analysis Lab in Abu Dhabi and forming a strategic partnership in Italy with Bianalisi. The company is publicly listed and trades under the ticker CNTG.

CENTOGENE was founded in 2006 with an initial focus on addressing the complete patient journey for rare-disease diagnostics. According to the company's own account, it was "born to help diagnostic patients with rare disease" and has since evolved to serve patients across all clinical specialties. Its headquarters are in Rostock, Germany, where it also operates as a training company; it was named a "Top Training Company 2021" ("Top Ausbildungsbetrieb 2021") by the Chamber of Industry and Commerce – Rostock. Over its roughly two decades of operation, CENTOGENE built a global footprint. Its business locations include Rostock, Berlin, Boston, Valencia, Belgrade, São Paulo and Delhi, with additional presence in Dubai and, more recently, Taiwan through CENTOGENE APAC. The company employs people from over 50 nations. A central asset of the company is the CENTOGENE Biodatabank, which has grown to include data on more than one million individuals, supported by more than 350 peer-reviewed scientific publications. This data foundation underpins both its diagnostic offerings and its pharma partnerships, through which it works with pharmaceutical companies to accelerate drug discovery and development using multiomic insights and real-world data. CENTOGENE has continued to expand its product portfolio. It introduced the CentoGenome Ultra-Fast whole-genome sequencing service, promising results in five business days, and the CentoDx genomic knowledge-management platform for variant interpretation. In 2026 it added CentoScreen Exome for reproductive carrier screening in low-risk couples and launched the CentoPediatric NGS panel portfolio focused on pediatric disorders. The company also deepened its regional commitments, opening a CENTOGENE APAC office in Taiwan and taking ownership in Pearl Medical Analysis Lab in Abu Dhabi, and it formed a strategic partnership in Italy with Bianalisi. CENTOGENE is publicly listed and trades under the ticker CNTG.

• 2026

  Launched CentoPediatric panel portfolio and CentoScreen Exome; opened CENTOGENE APAC office in Taiwan; took ownership in Pearl Medical Analysis Lab in Abu Dhabi.

• 2025

  Strategic partnership in Italy with Bianalisi; participation at ESHRE 2025 and ESC 2025.

• 2021

  Named "Top Training Company 2021" by the Chamber of Industry and Commerce – Rostock.

• 2006

  CENTOGENE founded with focus on rare-disease diagnostics.

Precision-medicine diagnostics and multiomic data partner for physicians, patients and pharma, with deep rare-disease expertise.

• CentoGenome

  Whole-genome sequencing offering.

• CentoGenome Ultra-Fast

  Whole-genome sequencing with results in just 5 business days.

• CentoScreen Exome

  Reproductive carrier screening designed for low-risk couples with no known family history of genetic disorders.

• CentoPediatric

  NGS panel area focused on pediatric disorders.

• CentoDx

  End-to-end genomic knowledge-management platform that streamlines variant interpretation.

• CentoCustom Panel

  Customizable precision diagnostics panels.

• CENTOGENE Biodatabank

  Data resource covering more than one million individuals.

• 2021.06.11

  Reported2021.06.11

  Lufthansa launches drive-through test and bag-drop service[6]Lufthansa推出驾车办理检测及行李托运服务futuretravelexperience.com

  Lufthansa partnered with Fraport and CENTOGENE to introduce a drive-through COVID-19 PCR test and baggage check-in service at Frankfurt Airport for passengers departing on Lufthansa, Swiss and Austrian Airlines.

• 2019.11.13

  Reported2019.11.13

  CENTOGENE and Pfizer sign data-access and collaboration agreement[7]CENTOGENE与辉瑞签署数据访问与合作协议finanznachrichten.de

  CENTOGENE announced a data-access and collaboration agreement with Pfizer. The agreement gives Pfizer access to CENTOGENE's data repository for potential discovery and validation of genetic and biochemical targets related to rare-disease therapies; the companies also plan to mine the repository and jointly agree on any collaborative research projects.

Read more

1. 1CENTOGENE Guiding Precision Medicinecentogene.com
2. 2News | CENTOGENEcentogene.com
3. 3Our Story | CENTOGENEcentogene.com
4. 4Careers | CENTOGENEcentogene.com
5. 5Centogene N.V. – Wikidatawikidata.org
6. 6Lufthansa推出驾车办理检测及行李托运服务futuretravelexperience.com
7. 7CENTOGENE与辉瑞签署数据访问与合作协议finanznachrichten.de